<SEC-DOCUMENT>0001193125-23-306010-index.html : 20231229 <SEC-HEADER>0001193125-23-306010.hdr.sgml : 20231229 <ACCEPTANCE-DATETIME>20231229170025 ACCESSION NUMBER: 0001193125-23-306010 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 GROUP MEMBERS: FAIRMOUNT HEALTHCARE CO-INVEST LP GROUP MEMBERS: FAIRMOUNT HEALTHCARE FUND II LP GROUP MEMBERS: FAIRMOUNT HEALTHCARE FUND LP GROUP MEMBERS: PETER HARWIN GROUP MEMBERS: TOMAS KISELAK SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Spyre Therapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89456 FILM NUMBER: 231528405 BUSINESS ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6176515940 MAIL ADDRESS: STREET 1: 221 CRESCENT STREET STREET 2: BUILDING 23, SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: Aeglea BioTherapeutics, Inc. DATE OF NAME CHANGE: 20150311 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Fairmount Funds Management LLC CENTRAL INDEX KEY: 0001802528 ORGANIZATION NAME: IRS NUMBER: 364841215 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 200 BARR HARBOR DRIVE STREET 2: SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 267-262-5300 MAIL ADDRESS: STREET 1: 200 BARR HARBOR DRIVE STREET 2: SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D/A <SEQUENCE>1 <FILENAME>d67883dsc13da.htm <DESCRIPTION>SC 13D/A <TEXT> Document 1 - file: d67883dsc13da.htm
</DOCUMENT> </SEC-DOCUMENT>